BTIG analyst Julian Harrison downgraded Aerovate Therapeutics Inc (NASDAQ: AVTE) from Buy to Neutral.The analyst comments "AV-101 did not separate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE